6 O
ADVERSE O
REACTIONS O
Because O
clinical O
trials O
are O
conducted O
under O
widely O
varying O
conditions O
, O
adverse O
reaction O
rates O
observed O
in O
the O
clinical O
trials O
of O
a O
drug O
can O
not O
be O
directly O
compared O
to O
rates O
in O
the O
clinical O
trials O
of O
another O
drug O
and O
may O
not O
reflect O
the O
rates O
observed O
in O
clinical O
practice O
. O

EXCERPT O
: O
The O
most O
common O
ocular O
adverse O
reactions O
, O
occurring O
in O
less O
than O
4 O
% O
of O
eyes O
treated O
with O
LASTACAFT O
( O
r O
) O
, O
were O
eye O
irritation O
, O
burning O
and/or O
stinging O
on O
instillation O
, O
eye O
redness O
, O
and O
eye O
pruritus O
. O

( O
6.1 O
) O
To O
report O
SUSPECTED O
ADVERSE O
REACTIONS O
, O
contact O
Allergan O
at O
1-800-433-8871 O
or O
FDA O
at O
1-800-FDA-1088 O
or O
www.fda.gov/medwatch O
. O

6.1 O
Clinical O
Studies O
Experience O
The O
most O
frequent O
ocular B-OSE_Labeled_AE
adverse I-OSE_Labeled_AE
reactions I-OSE_Labeled_AE
, O
occurring O
in O
less O
than O
4 O
% O
of O
eyes O
treated O
with O
LASTACAFT O
( O
r O
) O
, O
were O
eye B-OSE_Labeled_AE
irritation I-OSE_Labeled_AE
, O
burning O
and/or O
stinging O
upon O
instillation O
, O
eye B-OSE_Labeled_AE
redness I-OSE_Labeled_AE
and O
eye B-OSE_Labeled_AE
pruritus I-OSE_Labeled_AE
. O

6.2 O
Non-ocular O
Adverse O
Reactions O
The O
most O
frequent O
non-ocular O
adverse O
reactions O
, O
occurring O
in O
less O
than O
3 O
% O
of O
subjects O
with O
eyes O
treated O
with O
LASTACAFT O
( O
r O
) O
, O
were O
nasopharyngitis B-OSE_Labeled_AE
and O
headache B-OSE_Labeled_AE
. O

Some O
of O
these O
events O
were O
similar O
to O
the O
underlying O
disease O
being O
studied O
. O

6.3 O
Postmarketing O
Experience O
The O
following O
adverse O
reactions O
have O
been O
identified O
during O
postmarketing O
use O
of O
LASTACAFT O
( O
r O
) O
in O
clinical O
practice O
. O

Because O
they O
are O
reported O
voluntarily O
from O
a O
population O
of O
unknown O
size O
, O
estimates O
of O
frequency O
can O
not O
be O
made O
. O

These O
reactions O
include O
: O
eye B-OSE_Labeled_AE
discharge I-OSE_Labeled_AE
, O
eye B-OSE_Labeled_AE
swelling I-OSE_Labeled_AE
, O
erythema B-OSE_Labeled_AE
of I-OSE_Labeled_AE
eyelid I-OSE_Labeled_AE
, O
eyelid B-OSE_Labeled_AE
edema I-OSE_Labeled_AE
, O
hypersensitivity B-OSE_Labeled_AE
, O
and O
somnolence B-OSE_Labeled_AE
. O

